Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).

× No keyword cloud information.

6 in total

Review 1. Multiple sclerosis.

Authors: Alastair Compston; Alasdair Coles
Journal: Lancet Date: 2002-04-06 Impact factor: 79.321

Review 2. The prevalence of multiple sclerosis in the world: an update.

Authors: G Rosati
Journal: Neurol Sci Date: 2001-04 Impact factor: 3.307

Review 3. Update on the treatment options for multiple sclerosis.

Authors: Masaaki Niino; Hidenao Sasaki
Journal: Expert Rev Clin Immunol Date: 2010-01 Impact factor: 4.473

4. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Authors: Ludwig Kappos; Ernst-Wilhelm Radue; Paul O'Connor; Chris Polman; Reinhard Hohlfeld; Peter Calabresi; Krzysztof Selmaj; Catherine Agoropoulou; Malgorzata Leyk; Lixin Zhang-Auberson; Pascale Burtin
Journal: N Engl J Med Date: 2010-01-20 Impact factor: 91.245

5. Effect of relapses on development of residual deficit in multiple sclerosis.

Authors: Fred D Lublin; Monika Baier; Gary Cutter
Journal: Neurology Date: 2003-12-09 Impact factor: 9.910

Review 6. Central nervous system-directed effects of FTY720 (fingolimod).

Authors: Veronique E Miron; Anna Schubart; Jack P Antel
Journal: J Neurol Sci Date: 2008-08-03 Impact factor: 3.181

6 in total